Due to COVID-19, HCA’s lobby is closed. Learn more about HCA's customer service options during the pandemic.

General Health Care Authority rulemaking

This page includes all of the current rule making activity for General Health Care Authority.

Definitions
Affected WAC: 182-51-0100
Formally proposed
Effective: 09/26/2021
Description: To correct a typographical error.
Agency contact:
Jason Crabbe, rule writer
360-725-9563
Expedited Adoption (CR105) - WSR 21-13-167
Filed date: 06/23/2021
Permanent Adoption (CR103P) - WSR 21-18-046
Effective: 09/26/2021
Patient Decision Aids
Patient decision aids
Affected WAC: 182-60-027, 182-60-040
Formally proposed
Effective: 09/26/2021
Description: HCA is amending WAC 182-60-027 to add patient representative to the list of panel members. Patient representatives add value to HCA’s patient decision aid (PDA) review advisory panels. After conducting several rounds of certification and recertification, HCA has determined that two years is too short of a time frame between the initial certification of a patient decision aid and its recertification. Therefore, HCA is amending 182-60-040 to change the length of time for certification of patient decision aids from two years to four years.
Agency contact:
Jason Crabbe, rule writer
360-725-9563
Preproposal (CR101) - WSR 21-10-030
Filed date:04/27/2021
Proposal (CR102) - WSR 21-15-099
Hearing date: 08/24/2021
*Comments due by 08/24/2021
Permanent Adoption (CR103P) - WSR 21-18-053
Effective: 09/26/2021
All Payor Claims Database
Registration requirements
Affected WAC: 182-70-040
Formally proposed
Effective: 09/26/2021
Description: HCA is adding a definition of de minimis to the section to specify a minimum reporting threshold below which a data supplier is not required to submit data.
Agency contact:
Jason Crabbe, rule writer
360-725-9563
Preproposal (CR101) - WSR 21-04-121
Filed date: 2/1/2021
Proposal (CR102) - WSR 21-15-100
Hearing date: 08/24/2021
*Comments due 08/24/2021
Permanent Adoption (CR103P) - WSR 21-18-057
Effective: 09/26/2021
Washington Rx Drug Pricing Program
Manufacturers - data and price reporting & data confidentiality
Affected WAC: 182-51-0600, 182-51-0900
Formally proposed
Effective: 05/23/2021
Description: HCA is amending WAC 182-51-0600 to change the timeframe manufacturers have to report to HCA new covered drugs being introduced to market in Washington. HCA is also amending WAC 182-51-0900 to add the contents of the Prescription Drug Pricing Transparency program’s nondisclosure agreement.
Agency contact:
Jason Crabbe, rule writer
360-725-9563
Preproposal (CR101) - WSR 20-22-098
Filed date: 11/3/2020
Proposal (CR102) - WSR 21-06-099
Hearing date: 4/6/2021
*Comments due 4/6/2021
Permanent Adoption (CR103P) - WSR 21-10-008
Effective: 05/23/2021